DNA repair in cancer therapy molecular targets and clinical applications

Bibliographic Details
Other Authors: Kelley, Mark Richard, 1957-
Format: Electronic
Published: London Waltham, MA : Elsevier/Academic Press, 2012.
Edition:1st ed.
Subjects:
Online Access:View fulltext via EzAccess
Table of Contents:
  • Introduction and overview of current targets: bench to clinic / Mark R. Kelley
  • 2. MGMT a critical DNA repair gene target for chemotherapy resistance / Stanton L. Gerson and Lili Liu
  • 3. Blockade of base excision repair: inhibition of small lesions results in big consequences to cancer cells / Melissa Fishel and Carlo Vascotto
  • 4. PARP inhibitors
  • scientific rationale and clinical development for cancer / Ruth Plummer, Nicola J. Curtin and Yvette Drew
  • 5. Chemotherapy intervention by inhibiting DNA polymerases for therapeutic intervention / Anthony J. Berdis
  • 6. Targeting the nucleotide excision repair pathway for therapeutic applications / John Turchi and Stephan M. Patrick
  • 7. Homologous recombination and ATM/ATR targets / Henning Willers, Lee Zou and Heike N. Pfaffle
  • 8. DNA double strand break repair by nonhomologous end joining and its clinical relevance / Michael Weinfeld and Susan Lees-Miller
  • 9. Defective MMR-c-Abl-p73-GADD45alpha expression in cancer chemoresistance / David Boothman and Long Shan Li
  • 10. DNA repair signaling targets / Susan Ashwell
  • 11. Redox regulation of DNA repair and therapeutic / Millie M. Georgiadis
  • 12. Personalized cancer medicine: DNA repair alterations is a promising predictive marker in cancer / Srinivasan Madhusudan
  • 13. The role of DNA damage and repair in neurotoxicity caused by cancer therapies / Michael R. Vasko
  • 14. Future directions with DNA repair inhibitors / Mark R. Kelley.